Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tangluoning (also known as Tang Luo Ning or TLN) is a traditional Chinese medicine compound prescription used primarily for the treatment of diabetic peripheral neuropathy. It is composed of multiple herbal ingredients and has been shown in preclinical and clinical studies to improve symptoms associated with diabetic neuropathy. The proposed mechanisms include modulation of glycolipid metabolism, reduction of oxidative stress, regulation of mitochondrial dynamics in Schwann cells, and rebalancing intestinal flora. Studies have demonstrated that TLN can decrease serum lipid levels, insulin resistance, blood glucose levels, reactive oxygen species (ROS), and improve mitochondrial function in nerve tissue[1][2][3][4]. Its effects are dose-dependent and it may also influence microRNA expression related to nerve repair[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tangluoning.